Literature DB >> 4443796

Circulating human interferon after intramuscular injection into animals and man.

K Cantell, L Pyhälä, H Strander.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4443796     DOI: 10.1099/0022-1317-25-3-453

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


× No keyword cloud information.
  6 in total

Review 1.  Interferons: anti-neoplastic drugs?

Authors:  H Strander
Journal:  Blut       Date:  1977-09-18

Review 2.  Interferon therapy: pharmacokinetic and pharmacological aspects.

Authors:  A Billiau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

3.  Receptor mediated pathways for interferon action: in vivo implications.

Authors:  K E Mogensen; M T Bandu; F Vignaux; G Uze; P Eid
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

4.  Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.

Authors:  J Vilcek; I T Sulea; I L Zerebeckyj; Y K Yip
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

5.  Influence of interferon on the growth of primary ovarian carcinoma cells in a semi-solid agar system: comparison with clinical effects of interferon therapy.

Authors:  P Ling; S Einhorn; I M Anjegård; G Brenning; N Einhorn; H Strander
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

6.  In vitro and in vivo effects of interferon on the response of human lymphocytes to mitogens.

Authors:  S Einhorn; H Blomgren; N Einhorn; H Strander
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.